Product image of Golexin La (Goserelin) supplied by GNH India

Golexin La

Active Ingredient:
Goserelin
Origin:
EU

Golexin La (Goserelin)

Golexin La is a prescription medication that contains the active ingredient goserelin, supplied as a subcutaneous injection. It is marketed in the European Union and is classified as a GnRH agonist used in hormone therapy. The product does not list a specific strength or dosage form beyond its injectable preparation, and it is intended for use under medical supervision.

Manufacturer / TM Owner

Amw Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Golexin La is prescribed for conditions that benefit from suppression of sex hormone production. It is commonly employed in oncology and reproductive endocrinology settings.

  • Treatment of advanced prostate cancer in men
  • Adjuvant therapy for hormone‑responsive breast cancer
  • Management of endometriosis symptoms
  • Reduction of uterine fibroid size
  • Control of central precocious puberty in children
  • Supportive care in certain fertility protocols

Side Effects

Golexin La can cause a range of side effects, some of which are expected during hormone suppression therapy. Patients should be monitored for both common and serious reactions.

Common

  • Hot flashes or night sweats
  • Injection site reactions such as redness or swelling
  • Decreased libido or erectile dysfunction
  • Mood changes including depression or anxiety
  • Fatigue or weakness
  • Bone pain or joint discomfort

Serious

  • Severe allergic reaction (anaphylaxis)
  • Cardiovascular events such as myocardial infarction
  • Significant bone mineral density loss leading to fractures
  • Acute liver injury
  • Severe injection site infection

Precautions & Warnings

Before initiating Golexin La, clinicians should evaluate patient history and monitor ongoing therapy for safety concerns.

  • Assess cardiovascular risk factors and baseline cardiac function
  • Evaluate bone health; consider calcium and vitamin D supplementation
  • Review history of hypersensitivity to GnRH analogues
  • Monitor liver function tests periodically
  • Use caution in patients with diabetes, as glucose control may be affected
  • Discuss potential impact on fertility and contraceptive needs

Avoid Interactions

Golexin La may interact with other medications that influence hormone levels or cardiovascular status. Interaction risk varies by drug class.

Avoid

  • Concurrent use of estrogen‑containing therapies that may counteract hormone suppression
  • Strong CYP3A4 inducers that could reduce goserelin exposure
  • Anticoagulants in patients with high thrombotic risk without monitoring

Use with caution

  • Bisphosphonates or denosumab for bone health
  • Antidepressants, especially SSRIs, due to overlapping mood effects
  • Antidiabetic agents, as glucose metabolism may change
  • NSAIDs, which can increase injection site irritation

Frequently Asked Questions

Golexin La is a prescription GnRH agonist that contains goserelin and is administered by subcutaneous injection, typically in a clinical setting.

Golexin La is commonly used as part of hormone therapy for advanced prostate cancer and hormone‑responsive breast cancer.

Yes, Golexin La is indicated for the management of endometriosis by reducing estrogen production, which can alleviate pain and lesion growth.

Golexin La is approved in some regions for reducing the size of uterine fibroids through hormonal suppression.

Golexin La acts as a synthetic analogue of GnRH, initially stimulating then down‑regulating pituitary receptors, which lowers LH and FSH and delays early puberty onset.

Common side effects include hot flashes, injection‑site reactions, decreased libido, mood changes, fatigue, and bone or joint discomfort.

Serious reactions can include severe allergic responses, cardiovascular events, significant bone loss leading to fractures, acute liver injury, and severe injection‑site infections.

Yes, because prolonged hormone suppression can affect bone mineral density, periodic bone health assessments are recommended.

Medications that contain estrogen or strong CYP3A4 inducers should generally be avoided, as they may reduce the effectiveness of Golexin La.

Bisphosphonates may be used to protect bone health, but they should be prescribed with caution and under medical supervision.

Regular monitoring of cardiovascular status, liver function, blood glucose, and bone density is advised during treatment.

Golexin La is not recommended for use during pregnancy; it is classified as a prescription‑only medication and should be avoided in pregnant individuals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Goserelin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT